More PRNewswire
View Older Stories View Newer Stories-
Evolent Announces Third Quarter 2024 Results
-
VyStar Credit Union and Orange County Head Start Honored with Prestigious Sargent Shriver Award by Florida Head Start Association
-
LIONSGATE AND LIONSGATE STUDIOS REPORT RESULTS FOR SECOND QUARTER FISCAL 2025
-
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter and Year to Date 2024 Financial Results on November 14, 2024
-
Accelerate Diagnostics Reports Third Quarter 2024 Financial Results
-
GoPro Announces Third Quarter Results
-
Genpact Reports Third Quarter 2024 Results
-
Safehold Receives BBB+ Credit Rating from S&P Global Ratings; Outlook Positive
-
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2024
-
Cryoport Reports Third Quarter 2024 Financial Results
-
Resideo Announces CEO Succession Plan and New Chairman of the Board
-
Cumberland Pharmaceuticals Reports Third Quarter 2024 Financial Results and Company Update
-
10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference
-
Artivion Reports Third Quarter 2024 Financial Results
-
DIAMONDROCK HOSPITALITY COMPANY REPORTS THIRD QUARTER 2024 RESULTS
-
OneStream Announces Third Quarter 2024 Financial Results
-
Rollins to Present at Upcoming Investor Conferences
-
4Front Ventures to Report Third Quarter 2024 Financial Results on November 14, 2024
-
Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year Guidance
-
Resideo Announces Third Quarter 2024 Financial Results
-
Lucid Announces Third Quarter 2024 Financial Results
-
Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights
-
International Tower Hill Mines Files 2024 Third Quarter Financial Results
-
VINCI PARTNERS REPORTS THIRD QUARTER 2024 EARNINGS RESULTS
-
Arcadium Lithium Releases Third Quarter 2024 Results
-
Enliven Therapeutics to Present at the Jefferies London Healthcare Conference
-
Serve Robotics to Acquire Autocado Robot Maker Vebu, Expanding Automation Offering
-
Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates
-
HotSpot Therapeutics Presents Additional Phase 1 Biomarker Data on Novel CBL-B Inhibitor HST-1011 at 2024 Society for Immunotherapy of Cancer Annual Meeting
-
Sapience Therapeutics Announces Participation at the Jefferies London Healthcare Conference
-
Fathom Holdings Reports Third Quarter 2024 Results
-
Lam Research Corporation Declares Quarterly Dividend
-
Natural Grocers by Vitamin Cottage, Inc. Announces Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast
-
Spyre Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Airbnb Announces Third Quarter 2024 Results
-
Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights
-
LightPath Technologies Reports First Quarter Fiscal 2025 Financial Results
-
KEYCORP LOWERS ITS PRIME LENDING RATE TO 7.75 PERCENT
-
Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
AKAMAI REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
-
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results
-
Axon reports Q3 2024 revenue of $544 million, up 32% year over year, raises outlook
-
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
-
AudioEye Reports Record Third Quarter 2024 Results
-
Siyata Mobile to Host Third Quarter 2024 Financial Results Call at 8:30 a.m. ET on November 15, 2024
-
AAON REPORTS RECORD SALES & EARNINGS FOR THE THIRD QUARTER OF 2024
-
AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for November 2024
-
Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Dynavax Announces $200 Million Share Repurchase Program
-
Cambium Networks Reports Third Quarter 2024 Financial Results
